| Patents for C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408) |
|---|
| 05/09/2006 | US7041670 Florfenicol-type antibiotics |
| 05/09/2006 | US7041668 Substituted benzimidazole compounds and their use for the treatment of cancer |
| 05/04/2006 | WO2006047504A1 Aromatic amides as inhibitors of c-fms kinase |
| 05/04/2006 | WO2006047302A1 Bissulfonamide compounds as agonists of galr1, compositions, and methods of use |
| 05/04/2006 | WO2006045518A1 Method for separating gas |
| 05/04/2006 | WO2006036512A3 Unsubstituted and substituted 4-benzyl-1,3-dihydro-imidazole-2-thiones acting as specific or selective alpha2 adrenergic agonists and methods for using the same |
| 05/04/2006 | WO2006036497A3 4-(condensed cyclicmethyl)-imidazole-2-thiones acting as alpha2 adrenergic agonists |
| 05/04/2006 | US20060094882 Ambient-temperature molten salts and process for producing the same |
| 05/04/2006 | US20060094725 N-heterocyclic derivatives as NOS inhibitors |
| 05/04/2006 | CA2584465A1 Heterocyclic carbonyl compounds and their use as sgk-inhibitors |
| 05/04/2006 | CA2580690A1 Bissulfonamide compounds as agonists of galr1, compositions, and methods of use |
| 05/03/2006 | EP1652841A1 Novel phenantridine analogues and their use as inhibitors of hyperproliferation of T cells and/or keratinocytes |
| 05/03/2006 | EP1652523A1 Transdermal absorption preparation |
| 05/03/2006 | EP1652522A1 Sustained release tablet for oral use |
| 05/03/2006 | EP1651958A1 Novel chemiluminescent compounds and their use |
| 05/03/2006 | EP1651614A1 Method for the production of purified 1,3-substituted imidazolium salts |
| 05/03/2006 | EP1651613A1 4,5-dihydro-imidazole as p2x7 ion channel blockers |
| 05/03/2006 | EP1572665B1 1-n-phenylamino-1h-imidazole derivatives as aromatase inhibitors |
| 05/03/2006 | EP1280791B1 N-heteroarylmethyl-m-phenylenediamine derivative-containing dyes for keratin fibers and novel n-heteroarylmethyl-m-phenylenediamine derivatives |
| 05/03/2006 | EP1208091B1 Benzophenones as inhibitors of reverse transcriptase |
| 05/03/2006 | EP1099692B1 N,n-substituted cyclic amine derivatives |
| 05/03/2006 | CN1768055A 4-ring imidazole derivatives as modulators of metabotropic glutamate receptor-5 |
| 05/03/2006 | CN1767823A Asthma and allergic inflammation modulators |
| 05/03/2006 | CN1765893A Process for the preparation of arylethanoldiamines useful as agonists of the beta-3-adrenoceptor |
| 05/03/2006 | CN1765888A Allantoin synthesis process |
| 05/03/2006 | CN1765887A Preparation method of imidazole aromatic alcohol analog derivative with optical activity |
| 05/03/2006 | CN1765886A Process for the preparation of arylethanoldiamines useful as agonists of the beta-3-adrenoceptor |
| 05/02/2006 | US7038084 Viricides; Aids therapy |
| 05/02/2006 | US7038073 Synthesis of 2-alkyl amino acids |
| 05/02/2006 | US7038051 Imidazonaphthyridines |
| 05/02/2006 | US7037937 Cytotoxic compounds |
| 05/02/2006 | US7037927 Amides that inhibit vanilloid receptor subtype 1 (VR1) receptor |
| 05/02/2006 | CA2250426C Amidinohydrazones as protease inhibitors |
| 05/02/2006 | CA2174544C Method for using pharmaceutical compositions containing 2-(2-alkylphenylamino)-oxazolines, 2-(2-alkylphenyl-amino)-thiazolines and 2-(2-alkylphenylamino)-imidazolines as adrenergic agents |
| 04/27/2006 | WO2006044527A1 Imidazole derivatives as vanilloid receptor ligands |
| 04/27/2006 | US20060089399 Pyrazolyl carboxanilides for controlling unwanted microorganisms |
| 04/27/2006 | US20060089393 Heteroaryl substituted biphenyl derivatives as p38 kinase inhibitors |
| 04/27/2006 | US20060089356 Substituted imidazoles as cannabinoid receptor modulators |
| 04/27/2006 | US20060089334 Aminoalkylphosphonates and related compounds as edg receptor agonists |
| 04/27/2006 | DE102004051277A1 Heterocyclische Carbonylverbindungen Heterocyclic carbonyl |
| 04/27/2006 | CA2583392A1 Imidazole derivatives as vanilloid receptor ligands |
| 04/26/2006 | EP1650211A1 Process for preparing imidazopyran derivatives |
| 04/26/2006 | EP1648876A1 5-ht sb 2b /sb receptor antagonists |
| 04/26/2006 | CN1764648A hydroxamid acid derivatives as histone deacetylase (HDAC) inhibitors |
| 04/26/2006 | CN1764454A Cyclic protein tyrosine kinase inhibitors |
| 04/26/2006 | CN1763036A Novel potassium losartan crystal form |
| 04/26/2006 | CN1763014A Method for preparing prochloraz |
| 04/25/2006 | US7034057 Controlling tumor necrosis factor; antiinflamamtory agents, autoimmune disease |
| 04/25/2006 | US7034056 Aryl and biaryl compounds having MCH modulatory activity |
| 04/25/2006 | US7034055 2-aminoindane analogs |
| 04/25/2006 | US7034034 Substituted 2-cyclohexyl-4-phenyl-1H-imidazole derivatives |
| 04/25/2006 | US7034031 Modulators of TNF-α signaling |
| 04/25/2006 | US7034025 Administering to a mammal an effective dose of a cysteine derivatives containing heteroaromatic group for the treatment of arterial tension, embryogenesis, oncogenesis, diabetes, cell proliferation, and other diseases |
| 04/25/2006 | US7034015 Interleukin 1 beta and tumour necrosis factor alpha inhibitors |
| 04/25/2006 | US7033578 Antimycotic nail varnish composition |
| 04/20/2006 | WO2006041888A2 Substituted aryl or heteroarylsulfonylbutanamides for use as anti-inflammatory agents |
| 04/20/2006 | WO2006041119A1 Hydrazide derivatives |
| 04/20/2006 | WO2005113513A3 Aryl sulfonamides |
| 04/20/2006 | WO2005067446A3 Composition and method for preventing fouling in (meth)acrylic acid processes |
| 04/20/2006 | WO2005030705A9 Inhibitors of histone deacetylase |
| 04/20/2006 | US20060084699 Antagonists of the B2 receptor of bradykinin; analgesics; hyperalgesia and major algesia; cancer; nontoxic; industrial scale; 5-[[(2,4-dichloro-3-methylphenyl)sulphonyl]methylamino]-N-[[4-(4,5-dihydro-1H-imidazol-2-yl)phenyl]methyl]-N-methyl-pentanamide |
| 04/20/2006 | US20060084657 Piperazine derivative |
| 04/20/2006 | US20060084648 Ethynyl derivatives as factor xa inhibitors |
| 04/20/2006 | CA2793025A1 Fungicidal active ingredient combinations comprising fluoxastrobin and imidazole fungicides |
| 04/20/2006 | CA2582459A1 Substituted sulfones and methods of use |
| 04/19/2006 | EP1647548A1 Dictionic bishydrazones, dyeingcompositions containig at least one of these compounds, process of their preparation and uses thereoff |
| 04/19/2006 | EP1647546A1 Novel heteroaryl derivative |
| 04/19/2006 | EP1646661A2 Living radical polymerization initiator comprising a functional group capable of reacting with polypeptides or the like, comb polymer obtained therewith, polypeptide conjugates and drung obtained therefrom |
| 04/19/2006 | EP1646659A2 Improved pharmaceutical drug candidates and methods for preparation thereof |
| 04/19/2006 | EP1572198B1 New pharmaceutical compounds with alpha2receptor activity |
| 04/19/2006 | EP1420784B1 Compounds effecting glucokinase |
| 04/19/2006 | EP1339695B1 Farnesyltransferase inhibitors |
| 04/19/2006 | EP1253924B1 Nitrate salts of antimicrobial agents |
| 04/19/2006 | EP1064274B1 Benzenesulfonamide derivatives and their use as medicaments |
| 04/19/2006 | CN1761773A Novel imidazole compound and usage thereof |
| 04/19/2006 | CN1761650A Compounds, a process for their preparation and their use as dyes and pigments |
| 04/19/2006 | CN1760192A Cationic diazo compounds, compositions comprising them, methods for dyeing and kit |
| 04/19/2006 | CN1252050C Process for recovering caprolactam from aqueous caprolactam product using in situ prepared alkali amino caproate |
| 04/18/2006 | US7030214 Ureins derived from α, ω, diamino acids and process for their preparation |
| 04/18/2006 | US7030196 Process for reducing the molecular weight of polypropylene |
| 04/18/2006 | US7030144 Central nervous system disorders |
| 04/13/2006 | WO2006038587A1 Binuclear metal complex, metal complex dye, photoelectric transducer and photochemical battery |
| 04/13/2006 | WO2006023167A3 Process for producing n-halogenated organic compounds |
| 04/13/2006 | WO2006004931A3 Substituted azepine derivatives as serotonin receptor modulators |
| 04/13/2006 | WO2005103698A3 Methods and antibodies for nitrofuran detection |
| 04/13/2006 | WO2005087752A3 Substituted hydroxyethylamine aspartyl protease inhibitors |
| 04/13/2006 | US20060079697 1-substituted-4-nitroimidazole compound and process for producing the same |
| 04/13/2006 | US20060079691 Ionic liquids having [n(cf3)2]-anions |
| 04/13/2006 | US20060079593 Hexaarylbiimidazole compounds and photopolymerization initiator compositions containing the same |
| 04/13/2006 | US20060079563 Cyclic protein tyrosine kinase inhibitors |
| 04/13/2006 | US20060079530 Farnesyl transferase inhibitors |
| 04/13/2006 | US20060078758 Organometallic compounds and display device employing the same |
| 04/12/2006 | EP1646054A1 Acid-base mixture and ion conductor composed of such mixture |
| 04/12/2006 | EP1645616A1 Power transmission fluids with enhanced antishudder durability |
| 04/12/2006 | EP1644398A1 Specific glucocorticosteroid compound having anti- inflammatory activity |
| 04/12/2006 | EP1644397A1 Specific glucocorticosteroid compound having anti- inflammatory activity |
| 04/12/2006 | EP1644337A1 Melanocortin-4 receptor binding compounds and methods of use thereof |
| 04/12/2006 | EP1644326A1 Cathepsin cysteine protease inhibitors |
| 04/12/2006 | EP1644321A2 New benzamides as ppaty modulators |
| 04/12/2006 | EP1644320A1 Indane derivates as muscarinic receptor agonists |